HOME >> MEDICINE >> NEWS
Studies suggest investigational agent reduces disease activity in MS

BOSTON A new drug under investigation shows a reduction in disease activity in multiple sclerosis (MS), according to two studies that will be presented at the American Academy of Neurology's 59th Annual Meeting in Boston, April 28 May 5, 2007. The drug reduced disease activity as indicated by MRI scans.

Both of the studies involved people with the relapsing-remitting form of MS, where symptoms flare up and then subside. By 24 weeks, treatment with the drug rituximab reduced the number of areas of brain damage, or lesions, in people with MS and the number of relapses, or times when symptoms flare up, when compared with placebo.

Rituximab is a therapeutic antibody that selectively targets and depletes a subset of immune cells called B-cells by targeting a specific protein on their surface.

"This is the first drug to target B-cells and may represent a potential new treatment strategy for relapsing-remitting MS," said study author Stephen Hauser, MD, of the University of California, San Francisco, and a member of the American Academy of Neurology. "While these are early stage clinical trials, these results are exciting, because the current drugs available for MS are only partially effective in reducing disease activity and preventing exacerbations. New and more effective treatments for MS are sorely needed, especially for people who do not adequately respond to currently available medications. These data are also important because they demonstrate that B-cells, which are the precursors of antibody-producing cells, play an essential role in mediating relapses of MS."

In the first study, a randomized, placebo-controlled trial, 69 people were given two infusions of rituximab two weeks apart and 35 were given a placebo. The participants were followed for six months. Those given rituximab had approximately 90 percent fewer brain lesions than those given placebo. During the six-month period, 58 percent fewer of those taking the d
'"/>

Contact: Angela Babb
ababb@aan.com
651-695-2789
American Academy of Neurology
1-May-2007


Page: 1 2 3

Related medicine news :

1. Studies show antidepressants not linked to birth defects
2. Studies show role of age, gender, race and weight on cancer risk and treatment
3. Studies highlight advances in diagnosis, medical therapy
4. Studies highlight real world use, safety of drug-eluting stents
5. Studies led by Rhode Island Hospital confirm safety and efficacy
6. Studies identify food sources of disease and drug resistance
7. Studies provide new evidence on risks associated with Cox-2 inhibitors and NSAIDs
8. Studies highlight need to monitor heart function in breast cancer patients
9. Studies examine physician disclosure of medical errors
10. Studies indicate medication can be an effective therapy for smoking cessation
11. Studies evaluating health effects of dental amalgam fillings in children confirm safety

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/1/2020)... ... September 01, 2020 , ... Board certified plastic surgeon Sepideh ... office will be the first to bear her name, Dr. Saber has regularly ... lift), as well as rhinoplasty, facial rejuvenation, and many more in association with ...
(Date:9/1/2020)... ... 2020 , ... Feeding Matters , the first organization in the world ... is pleased to announce that the U.S. Centers for Disease Control and Prevention (CDC) ... next edition of the U.S. International Classification of Diseases (ICD ) on October ...
(Date:9/1/2020)... ... September 01, 2020 , ... Dr. Kiran ... in aesthetic surgery of the face, breast, and body. In 2018, she founded ... boutique plastic surgery and aesthetic practice in Southwest Florida. Dr. Gill and her ...
(Date:8/31/2020)... (PRWEB) , ... August 31, 2020 , ... ... largest non-profit organization devoted exclusively to funding innovative lymphoma research and serving the ... services – today announced the 10th Anniversary of Blood Cancer Awareness Month (BCAM) ...
(Date:8/31/2020)... ... August 31, 2020 , ... Ocean Springs, ... masks to medical first responders across the United States. Since the start of ... protective equipment (PPE) medical centers , hospitals , firefighters , ...
Breaking Medicine News(10 mins):
(Date:9/1/2020)... ... 01, 2020 , ... Mara C. Weinstein Velez, M.D., FAAD ... University of Rochester Medical Center, in Upstate New York. She completed a prestigious ... faculty from the Harvard and Yale Departments of Dermatology and is one of ...
(Date:9/1/2020)... ... ... Breast and ovarian cancers are common diseases that affect many women. ... 7,500 women per year) and 10% of ovarian cancers (about 2,000 women per year) ... detectable in the Women’s Excellence Genetic Testing Program. , Dr. Jonathan Zaidan, MD, FACOG, ...
(Date:8/31/2020)... ... ... in New York City you will always pay more for these two things: real estate ... demand, but are plastic surgeons in New York worth the premium prices that they charge? ... four-hour trip to have expert aesthetic treatments by some of the best doctors in the ...
Breaking Medicine Technology:
Cached News: